These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17290453)

  • 1. Oromandibular dystonia involving the lateral pterygoid muscles: four cases with different complexity.
    Møller E; Bakke M; Dalager T; Werdelin LM
    Mov Disord; 2007 Apr; 22(6):785-90. PubMed ID: 17290453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oromandibular dystonia and hormonal factors: twelve years follow-up of a case report.
    Michelotti A; Silva R; Paduano S; Cimino R; Farella M
    J Oral Rehabil; 2009 Dec; 36(12):916-21. PubMed ID: 19840357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oromandibular dystonia: long-term management with botulinum toxin.
    Sinclair CF; Gurey LE; Blitzer A
    Laryngoscope; 2013 Dec; 123(12):3078-83. PubMed ID: 24122897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of dystonia of the lateral pterygoid muscle with botulinum toxin A.
    Mendes RA; Upton LG
    Br J Oral Maxillofac Surg; 2009 Sep; 47(6):481-3. PubMed ID: 18829144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia.
    Singer C; Papapetropoulos S
    Parkinsonism Relat Disord; 2006 Mar; 12(2):115-8. PubMed ID: 16271495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
    Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
    Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oromandibular dystonia.
    Lee KH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Oct; 104(4):491-6. PubMed ID: 17689275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations.
    Papapetropoulos S; Singer C
    Head Face Med; 2006 Dec; 2():47. PubMed ID: 17156419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Movement-related cortical potentials before jaw excursions in oromandibular dystonia.
    Yoshida K; Kaji R; Kohara N; Murase N; Ikeda A; Shibasaki H; Iizuka T
    Mov Disord; 2003 Jan; 18(1):94-100. PubMed ID: 12518306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oromandibular dystonia following dental treatment: case reports and discussion.
    Thorburn DN; Lee KH
    N Z Dent J; 2009 Mar; 105(1):18-21. PubMed ID: 19418679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oromandibular dystonia. Clinical forms, diagnosis and examples of therapy with botulinum toxin].
    Laskawi R; Rohrbach S
    Laryngorhinootologie; 2001 Dec; 80(12):708-13. PubMed ID: 11793266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oromandibular dystonia, mental distress and oro-facial dysfunction-A follow-up 8-10 years after start of treatment with botulinum toxin.
    Bakke M; Baram S; Dalager T; Biernat HB; Møller E
    J Oral Rehabil; 2019 May; 46(5):441-449. PubMed ID: 30664806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronoidotomy as treatment for trismus due to jaw-closing oromandibular dystonia.
    Yoshida K
    Mov Disord; 2006 Jul; 21(7):1028-31. PubMed ID: 16552755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.
    Tan EK; Jankovic J
    Neurology; 1999 Dec; 53(9):2102-7. PubMed ID: 10599789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing the therapeutic effect of muscle afferent block for oromandibular dystonia and dyskinesia: implications for their distinct pathophysiology.
    Yoshida K; Kaji R; Shibasaki H; Iizuka T
    Int J Oral Maxillofac Surg; 2002 Oct; 31(5):499-505. PubMed ID: 12418565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.
    Dadgardoust PD; Rosales RL; Asuncion RM; Dressler D
    J Neural Transm (Vienna); 2019 Feb; 126(2):141-148. PubMed ID: 30604200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-Guided OnabotulinumtoxinA Injections to Treat Oromandibular Dystonia in Cerebral Palsy.
    Reyes FI; Shoval HA; Tenaglia A; Kim H
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Botulinum toxin type A treatment of cosmetically disturbing masseteric hypertrophy].
    Rijsdijk BA; van ES RJ; Zonneveld FW; Steenks MH; Koole R
    Ned Tijdschr Geneeskd; 1998 Mar; 142(10):529-32. PubMed ID: 9623101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition].
    Budrewicz S; Koszewicz M; Góral M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of botulinum toxin treatment for oromandibular dystonia.
    Comella CL
    Toxicon; 2018 Jun; 147():96-99. PubMed ID: 29453996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.